The Cancer Institute of New Jersey

Site:	The Cancer Institute of New Jersey	Go to their website
Address:	195 Little Albany St.
City:	New Brunswick
State:	NJ
Zip:	08903
Country:	USA

Phase	Trial	Trial Status	Site Status	Drug	NCT#
1	Study of XL820 Given Orally Daily to Subjects With Solid Tumors	Completed	Closed	XL820	NCT00350831
1	Study of XL820 in Adults With Solid Tumors	Completed	Closed	XL820	NCT00129571
3	A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (intrigue)	Active, not recruiting	Active	QINLOCK Ripretinib DCC-2618 SUTENT Sunitinib	NCT03673501